Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 10 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; acacia; white beeswax; calcium hydrogen phosphate dihydrate; stearic acid; maize starch; macrogol 6000; tartaric acid; purified talc; sucrose; povidone; carnauba wax; titanium dioxide; soluble maize starch - spasm of the gastrointestinal tract

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - hyoscine butylbromide - oral tablet - 10mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 10mg - tablet - 10 mg - active: hyoscine butylbromide 10mg excipient: acacia amylodextrin calcium phosphate carnauba wax colloidal silicon dioxide ethanol macrogol 6000 maize starch povidone purified talc stearic acid sucrose tartaric acid titanium dioxide white beeswax - muscle spasm of the gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - spasm of the gastrointestinal tract.

Malta - English - Medicines Authority

sanofi malta limited - hyoscine butylbromide - coated tablet - hyoscine butylbromide 10 mg - drugs for functional gastrointestinal disorders

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20mg - film coated tablet - 20 mg - active: hyoscine butylbromide 20mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 85g18490 povidone purified water - for the treatment of muscle spasm of the gastrointestinal tract relief of acute stomach ache and pain due to cramps and spasms (as stated on label)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxepin hydrochloride, quantity: 56.5 mg (equivalent: doxepin, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; carnauba wax; purified talc; sodium starch glycollate; diethyl phthalate; magnesium stearate; titanium dioxide; indigo carmine; erythrosine; povidone - the 50mg and 75mg tablets are indicated only for the maintenance treatment of major depression. (see precautions).

Singapore - English - HSA (Health Sciences Authority)

opella healthcare singapore pte. ltd. - hyoscine butylbromide - tablet, sugar coated - 10 mg - hyoscine butylbromide 10 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim limited - hyoscine butylbromide - coated tablets - 10 milligram - belladonna alkaloids, semisynthetic, quaternary ammonium compounds

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.